# CRISPR Therapeutics AG: Form 8-K, filed Nov 16, 2023

- Company: [CRISPR Therapeutics AG](/companies/crsp.md) (CIK 1674416)
- Form: 8-K
- Filed: 2023-11-16
- Accepted by EDGAR: Nov 16, 2023, 07:21 ET
- Period: 2023-11-15
- Accession: 0000950170-23-064341
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1674416/000095017023064341/crsp-20231115.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1674416/000095017023064341/

## Items reported

- Item 8.01: Other events

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1674416/000095017023064341/crsp-20231115.htm

Filed Nov 16, 2023.
Source: SEC EDGAR, the filing index for accession 0000950170-23-064341. Last ingested by Listed: Nov 2, 2026, 20:24 ET. No prices; not investment advice.